Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
85.91-88.66
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
7-8 2.5-6.25 <0.9
General Information
Revision date
2022-03-16
Product name
SOTROVIMAB (VIR-7831) DRUG PRODUCT
Product Synonyms
SOTROVIMAB INJECTION 500 MG (62.5 MG/ML) FOR INTRAVENOUS INFUSION *
supplier name
GlaxoSmithKline Korea
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Not classified. B. Warning label items including precautionary statement
Hazard pictograms
None.
Signal word
None.
Hazard statements
The mixture does not meet the criteria for classification.
Precautionary statements
None. C. Other hazards not included Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
6.25 % of the mixture consists of component(s) of unknown acute oral toxicity. 14.25 % of the mixture consists of component(s) of unknown acute dermal toxicity. 14.25 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 14.25 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.